First orphan drug for achondroplasia is validated
BioMarin Pharmaceutical Inc. recently announced that the European Medicines Agency [...]
BioMarin Pharmaceutical Inc. recently announced that the European Medicines Agency [...]
The Conference is a great opportunity to network and exchange invaluable knowledge with all stakeholders in the rare disease community
5 - 6th March 2020, Birmingham. Birmingham Children’s Hospital, a [...]
The call for healthcare providers to join the 24 existing [...]